Cargando…

CEBPD amplification and overexpression in urothelial carcinoma: a driver of tumor metastasis indicating adverse prognosis

The molecular aberrations responsible for the progression of urothelial carcinoma (UC) remain largely obscure. To search candidate driver oncogenes in UC, we performed array-based genomic hybridization (aCGH) on 40 UBUC samples. Amplification of 8q11.21 was preferentially identified in patients who...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yu-Hui, Wu, Wen-Jeng, Wang, Wei-Jan, Huang, Hsuan-Ying, Li, Wei-Ming, Yeh, Bi-Wen, Wu, Ting-Feng, Shiue, Yow-Ling, Sheu, Jim Jinn-Chyuan, Wang, Ju-Ming, Li, Chien-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741589/ https://www.ncbi.nlm.nih.gov/pubmed/26307680

Ejemplares similares

The biological impacts of CEBPD on urothelial carcinoma development and progression
por: Chan, Ti-Chun, et al.
Publicado: (2023)

Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis
por: Chan, Ti‐Chun, et al.
Publicado: (2021)

Angiogenesis Driven by the CEBPD–hsa-miR-429–VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression
por: Chan, Ti-Chun, et al.
Publicado: (2022)

Amplification-driven BCL6-suppressed cytostasis is mediated by transrepression of FOXO3 and post-translational modifications of FOXO3 in urinary bladder urothelial carcinoma
por: Wu, Wen-Ren, et al.
Publicado: (2020)

Sulfatase-1 overexpression indicates poor prognosis in urothelial carcinoma of the urinary bladder and upper tract
por: Lee, Hsiang-Ying, et al.
Publicado: (2017)

SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma
por: Chan, Ti-Chun, et al.
Publicado: (2020)

Necdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

Prognostic Utility of FBLN2 Expression in Patients With Urothelial Carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2020)

CSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma
por: Lee, Yi-Ying, et al.
Publicado: (2016)

MCM10 overexpression implicates adverse prognosis in urothelial carcinoma
por: Li, Wei-Ming, et al.
Publicado: (2016)

CEBPD Potentiates the Macrophage Inflammatory Response but CEBPD Knock-Out Macrophages Fail to Identify CEBPD-Dependent Pro-Inflammatory Transcriptional Programs
por: Spek, C. Arnold, et al.
Publicado: (2021)

Role of Microtubule-Associated Protein 1b in Urothelial Carcinoma: Overexpression Predicts Poor Prognosis
por: Chien, Tsu-Ming, et al.
Publicado: (2020)

DDR2 overexpression in urothelial carcinoma indicates an unfavorable prognosis: a large cohort study
por: Tsai, Meng-Chen, et al.
Publicado: (2016)

Overexpression of wild type or a Q311E mutant MB21D2 promotes a pro‐oncogenic phenotype in HNSCC
por: Gracilla, Daniel E., et al.
Publicado: (2020)

Astrocytic Cebpd Regulates Pentraxin 3 Expression to Promote Fibrotic Scar Formation After Spinal Cord Injury
por: Wang, Shao-Ming, et al.
Publicado: (2023)

Metformin promotes apoptosis in hepatocellular carcinoma through the CEBPD-induced autophagy pathway
por: Tsai, Hsin-Hwa, et al.
Publicado: (2017)

DPP4/CD26 overexpression in urothelial carcinoma confers an independent prognostic impact and correlates with intrinsic biological aggressiveness
por: Liang, Peir-In, et al.
Publicado: (2016)

The cAMP responsive element binding protein 1 transactivates epithelial membrane protein 2, a potential tumor suppressor in the urinary bladder urothelial carcinoma
por: Li, Chien-Feng, et al.
Publicado: (2015)

SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma
por: Ma, Li-Jung, et al.
Publicado: (2016)

Hypoxia-regulated MicroRNA-210 Overexpression is Associated with Tumor Development and Progression in Upper Tract Urothelial Carcinoma
por: Ke, Hung-Lung, et al.
Publicado: (2017)

Fibroblast CEBPD/SDF4 axis in response to chemotherapy-induced angiogenesis through CXCR4
por: Chi, Jhih-Ying, et al.
Publicado: (2021)

RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer
por: Wang, Xiangyu, et al.
Publicado: (2018)

SUMOylation of PUM2 promotes the vasculogenic mimicry of glioma cells via regulating CEBPD
por: Wang, Di, et al.
Publicado: (2020)

CSF-1 Overexpression Predicts Poor Prognosis in Upper Tract Urothelial Carcinomas
por: Hsu, Wei-Chi, et al.
Publicado: (2019)

HuR cytoplasmic expression is associated with increased cyclin A expression and poor outcome with upper urinary tract urothelial carcinoma
por: Liang, Peir-In, et al.
Publicado: (2012)

CEBPD modulates the airway smooth muscle transcriptomic response to glucocorticoids
por: Kan, Mengyuan, et al.
Publicado: (2022)

Complement Component 1, s Subcomponent Overexpression is an Independent Poor Prognostic Indicator in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

Prognostic Significance of ROR2 Expression in Patients with Urothelial Carcinoma
por: Yeh, Cheng-Fa, et al.
Publicado: (2021)

AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis
por: Li, Chien-Feng, et al.
Publicado: (2014)

SERPINE2 Overexpression Is Associated with Poor Prognosis of Urothelial Carcinoma
por: Chuang, Hao-Wen, et al.
Publicado: (2021)

Prognostic Impact of Thrombospodin-2 (THBS2) Overexpression on Patients with Urothelial Carcinomas of Upper Urinary Tracts and Bladders
por: Chang, I-Wei, et al.
Publicado: (2016)

Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling
por: Lin, Chung-Ming, et al.
Publicado: (2017)

A hierarchical and collaborative BRD4/CEBPD partnership governs vascular smooth muscle cell inflammation
por: Wang, Qingwei, et al.
Publicado: (2021)

Utility of EFEMP1 in the Prediction of Oncologic Outcomes of Urothelial Carcinoma
por: Chen, Tzu-Ju, et al.
Publicado: (2021)

Application of simulation-based CYP26 SNP-environment barcodes for evaluating the occurrence of oral malignant disorders by odds ratio-based binary particle swarm optimization: A case-control study in the Taiwanese population
por: Chen, Ping-Ho, et al.
Publicado: (2019)

YWHAZ amplification/overexpression defines aggressive bladder cancer and contributes to chemo‐/radio‐resistance by suppressing caspase‐mediated apoptosis
por: Yu, Chia‐Cheng, et al.
Publicado: (2019)

Identification of potential genes in upper tract urothelial carcinoma using next-generation sequencing with bioinformatics and in vitro analyses
por: Lee, Hsiang-Ying, et al.
Publicado: (2021)

Integrated analysis of pivotal biomarker of LSM1, immune cell infiltration and therapeutic drugs in breast cancer
por: Tzeng, Yen‐Dun Tony, et al.
Publicado: (2022)

Prognostic Value of Comorbidity for Patients with Upper Tract Urothelial Carcinoma after Radical Nephroureterectomy
por: Ke, Hung-Lung, et al.
Publicado: (2022)

HER2 Protein Overexpression and Gene Amplification in Plasmacytoid Urothelial Carcinoma of the Urinary Bladder
por: Kim, Bohyun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qa7ttrp4s76okrldiebbknmstm